Global Bio-protein Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-04-23
- Report ID: 104627
- Pages: 114
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Bio-protein Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Bio-protein Drug Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Bio-protein Drug Market
Abbott Laboratories
Bayer AG
Eli Lilly and Company
Amgen Inc.
Biocon Ltd.
Dr. Reddy's Laboratories
Roche
Fresenius kabi
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis AG
Panacea Biotec
ProBioGen AG
Sanofi
Reliance Life Science Pvt. Ltd.
...
Major Type of Bio-protein Drug Covered in Prudent Markets report:
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Application Segments Covered in Prudent Markets Market
Pharma and Biotech Companies
CROs
Academics
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Bio-protein Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Monoclonal Antibodies -Product Introduction and Major Manufacturers
1.1.2 Therapeutic Proteins -Product Introduction and Major Manufacturers
1.1.3 Vaccines -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Bio-protein Drug Status and Prospect (2015-2026)
2.1.1 China Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Bio-protein Drug Status and Prospect (2015-2026)
2.2.1 EU Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Bio-protein Drug Status and Prospect (2015-2026)
2.3.1 USA Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Bio-protein Drug Status and Prospect (2015-2026)
2.4.1 Japan Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Bio-protein Drug Status and Prospect (2015-2026)
2.5.1 India Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Bio-protein Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Bio-protein Drug Status and Prospect (2015-2026)
2.7.1 South America Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Bio-protein Drug Status and Prospect (2015-2026)
2.8.1 Bio-protein Drug Market Size and Growth Rate (2015-2026)
2.8.2 Bio-protein Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Bio-protein Drug Market Assessment by Segment
3.1 Global Bio-protein Drug Capacity and Growth Rate
3.2 Global Bio-protein Drug Sales by Type
3.3 Global Bio-protein Drug Sales Revenue by Type
3.4 Global Bio-protein Drug Consumption by Application
4 Global Bio-protein Drug Market Assessment by Regions
4.1 Global Bio-protein Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Bio-protein Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Bio-protein Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Bio-protein Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Bio-protein Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Bio-protein Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Bio-protein Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Bio-protein Drug Sales Revenue Market Share of Manufacturers (2019-2020)
7 Bio-protein Drug Competitive Analysis
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Profiles
7.1.2 Abbott Laboratories Product Introduction
7.1.3 Abbott Laboratories Bio-protein Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Bayer AG
7.2.1 Bayer AG Company Profiles
7.2.2 Bayer AG Product Introduction
7.2.3 Bayer AG Bio-protein Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Company Profiles
7.3.2 Eli Lilly and Company Product Introduction
7.3.3 Eli Lilly and Company Bio-protein Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Amgen Inc.
7.4.1 Amgen Inc. Company Profiles
7.4.2 Amgen Inc. Product Introduction
7.4.3 Amgen Inc. Bio-protein Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Biocon Ltd.
7.5.1 Biocon Ltd. Company Profiles
7.5.2 Biocon Ltd. Product Introduction
7.5.3 Biocon Ltd. Bio-protein Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Dr. Reddy's Laboratories
7.6.1 Dr. Reddy's Laboratories Company Profiles
7.6.2 Dr. Reddy's Laboratories Product Introduction
7.6.3 Dr. Reddy's Laboratories Bio-protein Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Roche
7.7.1 Roche Company Profiles
7.7.2 Roche Product Introduction
7.7.3 Roche Bio-protein Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Fresenius kabi
7.8.1 Fresenius kabi Company Profiles
7.8.2 Fresenius kabi Product Introduction
7.8.3 Fresenius kabi Bio-protein Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Profiles
7.9.2 GlaxoSmithKline Product Introduction
7.9.3 GlaxoSmithKline Bio-protein Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Company Profiles
7.10.2 Johnson & Johnson Product Introduction
7.10.3 Johnson & Johnson Bio-protein Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Merck
7.12 Novartis AG
7.13 Panacea Biotec
7.14 ProBioGen AG
7.15 Sanofi
7.16 Reliance Life Science Pvt. Ltd.
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
